With growing incidence rates of cardiovascular diseases (CVD), heart failure, and coronary artery disease, India represents one of the largest and fastest-growing markets for the global cardiovascular medical device industry. Major cardiovascular device subcategories utilized across clinical, interventional, and surgical settings in India include:
- Diagnostic devices such as blood pressure monitors, EKG (ECG in British English) devices and arrhythmia detectors
- Circulatory support devices such as CPR devices, artificial hearts and compressible limb sleeves
- Interventional cardiology devices such as coronary stents, aortic stents and valve replacements
- Implantable electrophysiology devices such as pacemakers, nerve stimulators and miniature defibrillators
- Vascular surgery devices such as endovascular grafts, IVC filters and vascular clamps
The Indian cardiovascular devices market is valued at approximately $1.55 billion. Cardiovascular disease is the leading cause of mortality in India. An estimated 60 million to 75 million citizens live with cardiovascular conditions, including ischemic heart disease, heart failure, and cardiac arrhythmias. Annual percutaneous coronary intervention (PCI / angioplasty) procedure volumes have surged to 500,000+ procedures annually.
India continues to face a critical workforce deficit relative to its disease burden. India now has approximately 5,500 practicing cardiologists and 2,200 cardiovascular and thoracic surgeons . Top-tier clinical care is delivered in dedicated cardiac specialty institutions, such as the Asian Heart Institute (Mumbai), Narayana Health (Bengaluru), and B.M. Birla Heart Research Centre (Kolkata), as well as major hospital networks including Apollo Hospitals, Fortis Healthcare, Max Healthcare, and public flagship institutions including AIIMS.
Domestic players have gained significant market share, particularly in drug-eluting stents, balloon catheters, and structural heart devices, supported by government Production-Linked Incentive (PLI) schemes. Prominent Indian companies include Sahajanand Medical Technologies (SMT) (a major exporter of DES), Meril Life Sciences (developers of the Myval TAVR system), Translumina, Relsys Medical, and Opto Circuits. Leading global players include Medtronic, Boston Scientific, Abbott Laboratories, Terumo Corporation, Edwards Lifesciences, and Biotronik.
Last updated: August 3rd, 2026
